Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for VERU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -0.001M
March 31, 2026 0.00
December 31, 2025 -23.37M
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 -0.0033M
March 31, 2024 0.1503M
December 31, 2023 -37.11M
September 30, 2023 -2.249M
June 30, 2023 -5.824M
March 31, 2023 -2.651M
December 31, 2022 -0.2571M
September 30, 2022 -0.6674M
June 30, 2022 -0.154M
March 31, 2022 -0.0471M
December 31, 2021 -0.2099M
September 30, 2021 -0.2374M
June 30, 2021 -0.1711M
March 31, 2021 -108.71M
December 31, 2020 -0.6238M
September 30, 2020 0.0503M
June 30, 2020 -12.18M
Date Value
March 31, 2020 -1.636M
December 31, 2019 0.00
September 30, 2019 -0.133M
June 30, 2019 -3.60M
March 31, 2019 -9.332M
December 31, 2018 0.00
September 30, 2018 -1.00M
June 30, 2018 -1.988M
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.001M
December 31, 2014 0.00
September 30, 2014 0.5199M
June 30, 2014 0.0899M
March 31, 2014 0.0104M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 0.505M
Corcept Therapeutics, Inc. -9.42M
Johnson & Johnson -138.00M
Eli Lilly & Co. 1.601B
Lexicon Pharmaceuticals, Inc. -1.023M